Intuitive Surgical (NASDAQ:ISRG | ISRG Price Prediction) looks compelling ahead of its July 16 earnings report, and the setup rarely gets this clean for a category leader trading well below fair value. Shares sit at $413.58, down 26.71% YTD, while the 247 base-case target of $559.79 implies 35.35% upside. Wall Street sits higher still at $563.35, with 22 buy ratings against 2 sell.
Three Reasons the Decision Is Easy
Operating momentum is accelerating: Q1 2026 delivered non-GAAP EPS of $2.50 versus a $2.11 consensus (an 18.66% beat) on revenue of $2.77 billion, up 23% year over year. That is the fourth straight beat, following surprises of 13.22%, 20.65%, and 11.95%. Operating income jumped 47.95%. Da Vinci procedures grew ~16% and Ion procedures grew ~39%.
The moat is measurable: The installed base sits at 11,395 da Vinci systems and 1,041 Ion systems, generating $1.69 billion in Q1 instruments and accessories revenue. That is the recurring razor-and-blade annuity retirement portfolios want, on a business that crossed $10 billion in full-year revenue for the first time in FY2025.
Capital return with a fortress balance sheet: ISRG holds $7.98 billion in cash (up 210% YoY) and repurchased 2.3 million shares for $1.1 billion in Q1 alone.
Better Than the Obvious Alternative
Medtronic (NYSE:MDT) is the name investors reach for when they want robotic-surgery exposure with a dividend. ISRG wins the head-to-head decisively. Medtronic’s Hugo platform has limited traction against ISRG’s 11,395-system installed base, and ISRG’s 23% revenue growth operates in a different tier than MDT’s mature medtech mix. For a retirement account that wants compounding, ISRG’s FY2025 operating income growth of 25.4% settles it.
The Catalyst Is Days Away
Polymarket assigns a 97% combined probability that Q2 da Vinci procedure growth prints between 12.5% and 17.5%, sitting inside management’s 13.5% to 15.5% full-year guide. Composite sentiment reads 68.39, bullish. Q3 2025’s earnings day produced a 13.89% single-session gain after a 20.65% surprise. History has favored shares heading into the report.
ISRG shares look well-positioned heading into the July 16 report.
Contact [email protected] for any questions or corrections.
Top Gaining Stocks
Top Losing Stocks